• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CGS

COGSTATE LTD

0.00% ! $1.40
Market Cap $240.6M  !
Healthcare Biotechnology
Add to My Watchlist

Cogstate Limited is a neuroscience technology company optimizing brain health assessments... Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CGS
Ann: Update - Notification of buy-back - CGS 		21/03/25 0 116
21/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  116 
CGS
Ann: Update - Notification of buy-back - CGS 		20/03/25 0 108
20/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  108 
CGS
Ann: Update - Notification of buy-back - CGS 		19/03/25 0 147
19/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  147 
CGS
Ann: Update - Notification of buy-back - CGS 		18/03/25 0 137
18/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  137 
CGS
Ann: Update - Notification of buy-back - CGS 		17/03/25 0 143
17/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  143 
CGS
Ann: Update - Notification of buy-back - CGS 		13/03/25 0 157
13/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  157 
CGS
Ann: Update - Notification of buy-back - CGS 		12/03/25 0 118
12/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  118 
CGS
Ann: Update - Notification of buy-back - CGS 		11/03/25 0 116
11/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  116 

See All Discussions arrow Created with Sketch.

Timeline

Update - Notification of buy-back - CGS
21 Mar 08:24
 
Update - Notification of buy-back - CGS
20 Mar 08:42
 
Update - Notification of buy-back - CGS
19 Mar 08:18
 
Update - Notification of buy-back - CGS
18 Mar 08:19
 
Update - Notification of buy-back - CGS
17 Mar 08:26
 
Update - Notification of buy-back - CGS
13 Mar 08:21
 
View More arrow Created with Sketch.

Featured News

NEWS Maiden Gold Pour at Laverton Mill Completed as Brightstar’s CY25 Production and Revenue Ramp-Up
right-arrow Created with Sketch.
NEWS Drilling Kicks Off at Highly Prospective Austin Gold Project in WA
right-arrow Created with Sketch.
NEWS Unseasonal Rains Cause Disruption at Langer Heinrich Mine as Production Temporarily Suspended
right-arrow Created with Sketch.
NEWS Q Precious And Battery Metals Mobilizing Diamond Drill La Corne South Project
right-arrow Created with Sketch.
NEWS FDA Approves Telix’s Gozellix for New Prostate Cancer Imaging
right-arrow Created with Sketch.
NEWS Imugene's Azer-cel Granted FDA Fast Track Designation in Blood Cancer
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.40 		Change
0.000(0.00%) 		Mkt cap ! $240.6M
Open High Low Value Volume
$1.39 $1.41 $1.39 $125.6K 89.60K

Buyers (Bids)

No. Vol. Price($)
2 20057 $1.38
 

Sellers (Offers)

Price($) Vol. No.
$1.41 6400 1
View Market Depth
Last trade - 16.10pm 21/03/2025 (20 minute delay) ?
CGS (ASX) Chart

Top Stories

Week 12 wrap: Markets cautiously optimistic; US Fed & China pause rates, Aus and Canada defence

What was the big story this week? In my view, it's that the ASX closed on Friday at 7,931pts. We're slowly creeping back to the 8,000pts level we clocked in mid-Feb.
Big pharma targets Australia. Could tariffs break the market? What if the cost of life-saving medicine in Australia skyrocketed overnight @ all because of a trade war?That’s the risk as Big Pharma, led by U.S. giants like Pfizer, Johnson @ Johnson, and Merck push Washington to slap tariffs on Australian pharmaceuticals. Their target? The Pha...
Marvel Gold makes strategic Tanzanian acquisition while raising $4.2 million Marvel Gold Ltd has acquired a prospective gold project in Tanzania, and raised more than $4.2M in a share placement.
Gorilla says it's found linking structure after landing gold up to 6.1g/t in wider Lakeview intercept Gorilla Gold Mines Ltd has identified multiple lodes and a particularly thick intercept through drilling at its Lakeside prospect in WA
Australia's getting new crypto laws. Do they matter to you? (Not really) The Australian Treasury is "developing an innovative Australian digital asset industry" - confirmation regulations are to hit crypto.

Featured News

NEWS Drilling Kicks Off at Highly Prospective Austin Gold Project in WA
right-arrow Created with Sketch.
NEWS Maiden Gold Pour at Laverton Mill Completed as Brightstar’s CY25 Production and Revenue Ramp-Up
right-arrow Created with Sketch.
NEWS Imugene's Azer-cel Granted FDA Fast Track Designation in Blood Cancer
right-arrow Created with Sketch.
NEWS Syntara Advances Program with New Topical Treatment for Skin Scarring
right-arrow Created with Sketch.
NEWS Patronus Resources Boosts Strategic Holdings with 7.73% Investment in Emmerson Resources
right-arrow Created with Sketch.
NEWS Lucapa Diamond Company Secures Majority Stake in Project Lulo Joint-Venture with Finalization of Mineral Investment Contract
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.